Revenue, 2024 (US$M)
$0.0
Forecast, 2030 (US$M)
$0.0
CAGR, 2025 - 2030
-100%
Report Coverage
Thailand
No access to market insights

The osteoporosis prevalence among the country’s women aged less than 50 was less than 5%. The prevalence of this disease increased after the age of 50. The following table shows the age-specific prevalence of osteopenia and osteoporosis.

The rising disposable income, increasing awareness about health & wellness, and increasing awareness are among the major factors contributing to the women’s health market growth in the country.

For instance, in April 2023, Fuji Pharma launched Nextstellis (FSN-013) used for the prevention of pregnancy in Thailand. It is introduced to reduce the adverse effects of a combination of drugs containing estrogen.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Scope

Women's health market segmentation & scope
Application
Hormonal Infertility
Contraceptives
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Polycystic Ovary Syndrome (PCOS)
Drug Class
Hormonal Therapies
Bone Health Agents
Fertility Agents
GnRH Modulators
Pain and Symptom Management
Metabolic Agents
Others
Age
50 years and above
Postmenopausal Osteoporosis
Endometriosis & Uterine Fibroids
Menopause
Others
Others

Women's Health Market Companies

Name Profile # Employees HQ Website

Thailand women's health market

Thailand Women's Health Market Outlook Share, 2024 & 2030 (US$M)

Thailand women's health market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more